• Scientific evidence is mounting that SARS-CoV-2 can cause neurological damage in patients hospitalized with the infection.
• A recent study that appeared in the journal JAMA Network Open finds five times increased mortality risk in patients hospitalized with COVID-19, citing encephalopathy as the most common neurological disease found in the clinical setting.
• As more research is needed to understand how COVID-19 affects the brain, Brain Scientific appears poised to offer technology solutions as a leading player in the neurological diagnostics space.

As the world learns more about the novel SARS-CoV-2 virus, the evidence about neurological symptoms developed by patients who suffered from COVID-19 is mounting, and the market for Brain Scientific’s (OTCQB: BRSF) innovative products appears to expand. A recent article published in Medical News Today discusses findings of the observational study examining neurological issues in patients hospitalized with COVID-19. The research which appeared in the journal JAMA Network Open unveils that the most prevalent neurological symptom observed in the clinical setting was acute encephalopathy also finding a relationship between neurological issues and a higher risk of dying in the hospital in patients infected with the SARS-CoV-2 virus (https://ibn.fm/j0F22). Although COVID-19 is considered a respiratory disease that mainly affects patients’ pulmonary systems, research is increasingly documenting that the disease can affect many other organs and systems, including the brain. Since the start of the pandemic, it has been observed in a clinical setting that some patients with COVID-19 have also developed neurological symptoms. However, more than a year into the pandemic, medical professionals and scientists alike still do not fully understand the prevalence of neurological problems or their relationship with mortality risk. To help fill this literature gap, Dr. Sherry Chou and her research team from the University of Pittsburgh School of Medicine performed an interim analysis of patient data collected from two large global consortia involving 3,744 patients across three cohorts. The study’s goal was to examine the incidence, type and outcomes of neurological manifestations among patients hospitalized with COVID-19. What data revealed was astonishing. The first cohort involving 3,055 patients hospitalized with COVID-19, both with and without neurological symptoms, unveiled that the most prevalent clinically reported neurological sign was acute encephalopathy, found in 50% of patients, while the most frequent self-reported symptom was headache (38%), and the loss of taste or smell (28%). The second and third cohorts involving patients with confirmed neurological issues and those who had received a neurological consultation also show encephalopathy as the most common neurological issue (53% and 24%, respectively). Again, it was followed by headaches and the loss of taste and smell as the most common self-reporting neurological symptoms. Research also reveals that if a patient has neurological issues resulting from COVID-19, it increases their risk of dying while in hospital by five times. Authors suggest that a formal neurological consultation may be needed in cases where doctors suspect neurological symptoms in individuals testing positive for COVID-19. Although an association between neurological issues in COVID-19 patients and an increased risk of in-hospital mortality has been established, more research is needed to identify if these neurological symptoms are causing the increase in mortality. Notwithstanding some practical limitations of the study, it lays the groundwork for future research involving standardized protocols, which may be able to track patients with neurological issues after they leave the hospital. As we learn more about the novel SARS-CoV-2 virus, it is becoming increasingly clear that neurological diagnostics will be at the center of the future post-COVID-19 health care of patients who suffered from the infection. Dr. Chou, the lead author of the study, emphasizes that even if we eradicate the pandemic, there are already millions of survivors who need neurological help, and there is still plenty of work in years to come. As a commercial-stage health care company focused on developing innovative medical devices and software disrupting the brain diagnostics market, Brain Scientific is poised to be at the center stage of neurological diagnostics space offering solutions for this growing public health problem with its two commercialized and FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM). Committed to a vision to allow medical professionals to conduct brain activity studies and collect diagnostic information more quickly, Brain Scientific appears well-positioned to offer solutions for the growing market need in the post-pandemic world. For more information, visit the company’s website at www.BrainScientific.com/Invest-Now. NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

• Experienced automotive industry veteran joins IMC as new president.
• Dubois has served as a leader at some of the most prestigious automotive organizations in the industry.
• New exec looking to build team that will lead Canadian operations to surpass even most optimistic projections.

DSG Global (OTCQB: DSGT) has announced that Christian Dubois, an auto executive with more than three decades of experience in the automotive industry, has accepted the role of president of Imperium Motors Canada, a division of DSGT’s Imperium Motor Corp. (“IMC”). IMC is an EV sales, manufacturing and marketing company that is gaining momentum and gathering attention for offering a variety of affordable electric vehicles equipped for the North American market. “Great companies are built on quality personnel, and we have exceeded any expectations,” said DSG Global CEO Robert Silzer. “Growth at times takes longer than planned; however, it’s obvious the hires of late are the best in the industry and will certainly assist in our corporate growth.” Dubois has served as a leader at some of the most prestigious automotive organizations in the industry. Most recently, he was regional director of operations and regional director of acquisitions and dealer development with the Dilawri Group of Companies, Canada’s largest automotive group. Dubois has also been with BMW Canada and Mercedes-Benz Canada. Dilawri employs more than 4,000 employees and has 76 franchised dealerships representing 35 automotive brands. And those aren’t the only numbers worth mentioning from Dubois’s stellar career. Thus far, he has managed 41 stores, worked with the executive teams of most OEMs, and represented dealers on multiple dealer councils. Retailers under his supervision have sold an estimated 80,000 cars and trucks, resulting in company revenues of more than $6 billion. He has been instrumental in acquiring 17 dealerships and in winning 13 open points; he has also won 11 Retailer of the Year awards. “Christian’s notoriety and experience in the automotive industry will allow Imperium to advance quickly toward becoming a top electric vehicle company,” said Imperium Motors president and CEO Rick Curtis. “He has strong plans for achieving strong sales rapidly, and his track record speaks for itself. Christian will be invaluable to our future success.” Dubois joins Imperium Motor Corp. as it focuses on making its mark in the U.S. EV space. The company is committed to offering EVs that feature a great design and a green mindset, as well as outstanding performance and functionality. IMC offerings will include high-speed, mid-speed and low-speed electric cars, trucks, SUVs, vans, buses and scooters. “Everyone by now has heard that the future is electric, and Imperium is about to introduce electric mobility in new segments and to new customers with affordable products that will redefine value,” said Dubois. “I am extremely excited to join Imperium and build the team that will lead our Canadian operations to surpass even the most optimistic projections.” DSG Global is an emerging global technology company with an array of interconnecting businesses in some of the fastest-growing market sectors. With roots in the golf industry, in which it specializes in fleet management with patented analytics, mobile touch-screen engagement and electric golf carts under the Vantage Tag Systems (“VTS”) brand, the company is moving quickly with road-ready electric vehicles for sale in the first quarter of 2021 through its Imperium Motor Company subsidiary. To learn more about the company, please visit www.DSGTGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to DSGT are available in the company’s newsroom at https://ibn.fm/DSGT

• Clean Oceans campaign set to drive one of the largest ocean plastics cleanups in history.
• Campaign offers participants weekly prizes and one $50,000 grand prize.
• Powered by Lottery.com, WinTogether.org innovates the way charitable organizations raise funds and interact with donors.

WinTogether.org, a charitable sweepstakes platform powered by Lottery.com, has launched the Clean Oceans campaign to support Ocean Voyages Institute (“OVI”), whose goal is to remove one million pounds of plastics and ghost nets from the Great Pacific Garbage Patch (https://ibn.fm/5QM2c) “The teams at WinTogther.org and OVI are excited to announce the launch of the Clean Oceans campaign,” said Lottery.com CEO Tony DiMatteo. “We hope that our joint effort helps the public rally around this important issue and drives one of the largest cleanups of ocean plastics and ghost nets in history.” The Clean Oceans campaign, which launched in June and will run through Aug. 31, 2021, offers weekly prizes to participants as well as a $50,000 grand prize, sponsored by Lottery.com. Participants become eligible for those prizes by donating at https://wintogether.org. This campaign is the first time WinTogether.org has partnered with Causes.com and Countable, which serve major brands and nonprofits, including Tesla, Patagonia Inc. and Red Nose Day. WinTogether.org is also working on this campaign with Dollar Donation Club, whose pre-campaign work with OVI was central to the activation of the campaign. WinTogether.org is a charitable sweepstakes platform focused on building the future of philanthropy. Founded and operated by Lottery.com, WinTogether.org has innovated the way charitable organizations raise funds and interact with donors by gamifying charitable giving. As part of its fundraising efforts, WinTogether.org incentivizes donors to get involved by offering the opportunity to win cash prizes, once-in-a-lifetime experiences, and luxury prizes. WinTogether.org is aligned with the United Nations 17 Sustainable Development Goals and works with some of the largest nonprofits in the world to provide a new channel to raise awareness and funds, as well as provide opportunities for donors around the world to support worthwhile causes. A portion of the donations are received by the WinTogether Trust, a registered 501(c)(3) organization, which donates directly to the named campaign. AutoLotto Inc., doing business as Lottery.com, is a leading technology company that is transforming how, where and when lottery is played. Its engaging mobile and online platforms enable players and commercial partners located in the United States and internationally to remotely purchase legally sanctioned lottery games. Fans and subscribers look to Lottery.com for compelling, real-time results on more than 800 lottery games from more than 40 countries. Additionally, through WinTogether.org, Lottery.com is fundamentally changing how nonprofit donors are incentivized to action by gamifying charitable giving. In all that it does, Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives. On Feb. 22, 2021, the company entered into a definitive agreement with Trident Acquisitions Corp. (NASDAQ: TDAC) to become a publicly traded company. For more information, visit the company’s website at www.Lottery.com. NOTE TO INVESTORS: The latest news and updates relating to Lottery.com are available in the company’s newsroom at https://ibn.fm/Lottery Important Notice Regarding Forward-Looking Statements This press release contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements, other than statements of present or historical fact included in this presentation, regarding the proposed business combination, Trident and Lottery.com’s ability to consummate the proposed business combination, the benefits of the transactions and the combined company’s future financial performance, as well as the combined company’s strategy, future operations, estimated financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this press release, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Except as otherwise required by applicable law, Trident and Lottery.com disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this Current Report. Trident and Lottery.com caution you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of either Trident or Lottery.com. In addition, Trident cautions you that the forward-looking statements contained in this press release are subject to the following factors: (i) the occurrence of any event, change or other circumstances that could delay the business combination or give rise to the termination of the agreements related thereto; (ii) the outcome of any legal proceedings that may be instituted against Trident or Lottery.com following announcement of the transactions; (iii) the inability to complete the business combination due to the failure to obtain approval of the shareholders of Trident, or other conditions to closing in the merger agreement; (iv) the risk that the proposed business combination disrupts Lottery.com’s current plans and operations as a result of the announcement of the transactions; (v) Lottery.com’s ability to realize the anticipated benefits of the business combination, which may be affected by, among other things, competition and the ability of Lottery.com to grow and manage growth profitably following the business combination; (vi) costs related to the business combination; (vii) risks related to the rollout of Lottery.com’s business and the timing of expected business milestones; (viii) Lottery.com’s dependence on obtaining and maintaining lottery retail licenses or consummating partnership agreements in various markets; (ix) Lottery.com’s ability to maintain effective internal controls over financial reporting, including the remediation of identified material weaknesses in internal control over financial reporting relating to segregation of duties with respect to, and access controls to, its financial record keeping system, and Lottery.com’s accounting staffing levels; (x) the effects of competition on Lottery.com’s future business; (xi) risks related to Lottery.com’s dependence on its intellectual property and the risk that Lottery.com’s technology could have undetected defects or errors; (xii) changes in applicable laws or regulations; (xiii) the COVID-19 pandemic and its effect directly on Lottery.com and the economy generally; (xiv) risks related to disruption of management time from ongoing business operations due to the proposed business combination; (xv) risks relating to privacy and data protection laws, privacy or data breaches, or the loss of data; (xvi) the possibility that Lottery.com may be adversely affected by other economic, business, and/or competitive factors; (xvii) the ability of the campaign to raise sufficient funds to remove its stated goal of 1 million pounds of plastics and ghost nets from the ocean, or at all. Should one or more of the risks or uncertainties described in this Current Report materialize or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. Additional information concerning these and other factors that may impact the operations and projections discussed herein can be found in the reports that Trident has filed and will file from time to time with the SEC, including its Annual Report on Form 10-K/A for the fiscal year ended December 31, 2020. Trident’s SEC filings are available publicly on the SEC’s website at www.sec.gov. Important Information and Where to Find it The proposed business combination will be submitted to shareholders of Trident for their consideration. Trident has filed a Registration Statement on Form S-4 with the SEC which includes a preliminary proxy statement and will include a definitive proxy statement to be distributed to Trident’s stockholders in connection with Trident’s solicitation for proxies for the vote by Trident’s stockholders in connection with the proposed business combination and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to Lottery.com’s shareholders in connection with the completion of the proposed business combination. After the Registration Statement has been declared effective, Trident will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the proposed business combination. Trident’s shareholders and other interested persons are advised to read the preliminary proxy statement / prospectus and any amendments thereto and, once available, the definitive proxy statement / prospectus, in connection with Trident’s solicitation of proxies for its special meeting of shareholders to be held to approve, among other things, the proposed business combination, because these documents will contain important information about Trident, Lottery.com and the proposed business combination. Stockholders may also obtain a copy of the preliminary proxy statement or, once available, the definitive proxy statement, as well as other documents filed with the SEC regarding the proposed business combination and other documents filed with the SEC by Trident, without charge, at the SEC’s website located at www.sec.gov or by directing a request to Cody Slach, (949) 574-3860, TDAC@gatewayir.com. The information contained on, or that may be accessed through, the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release. Participants in the Solicitation Trident and its directors and officers may be deemed participants in the solicitation of proxies of Trident’s stockholders in connection with the proposed business combination. Lottery.com and its officers and directors may also be deemed participants in such solicitation. Security holders may obtain more detailed information regarding the names, affiliations and interests of certain of Trident’s executive officers and directors in the solicitation by reading Trident’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2020, and the Registration Statement and other relevant materials filed with the SEC in connection with the business combination when they become available. Information concerning the interests of Trident’s participants in the solicitation, which may, in some cases, be different than those of their stockholders generally, will be set forth in the proxy statement relating to the business combination when it becomes available. No Offer or Solicitation This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

Date: JULY 22-23, 2021 ONLINE LIVESTREAM Chief Patient officers and leaders of engagement, advocacy, communications and support services, are invited to attend the inaugural Chief Patient Officer Summit on July 22-23, 2021, organized by DGE. This online live-streaming event is driven to focus on opportunities and challenges faced by Chief Patient officers and executives while offering a seamless patient experience. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing b2b events. The global event company caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries. The CPO summit will offer a viable platform for professionals to join hands in identifying patient needs with meticulous research and analysis. It will also offer better diversity and inclusion in clinical trials as well as affordable access and patient support. This 2-day online live-streaming event provides insights into the concerning issues and solutions for smooth execution. The online event will be graced by the presence of eminent industry thinkers and speakers who will share their expert opinion and insights into effective ideas for working compliantly with patients and patient advocacy organizations. The CPO Summit Agenda: The 2-day event will cover discussions on fostering internal cross-functional partnerships with clinical operations and regulatory teams to bring the patient voice into clinical trial design. This summit will be a learning platform to understand the strategic global approaches for working with advocates in various health care systems around the globe. Participants can connect with peers and avail tips and valuable advice on how to make patient centricity part of their organization’s HR onboarding process. Discussions will include developing the best methods in advocacy and engagement roles pre and post clinical at small, mid and large companies. Executives will also discuss the impact of the pandemic, new and effective ideas in the digital scenario, and global strategies for harmonious communication among healthcare systems across the world. The main focus of the event is to ensure the growth of patient officers and successful communication across the medical spectrum for an enhanced patient experience. To know more about the event, please visit https://ibn.fm/fcnes.

• Cannabis sales in California hit $4.4 billion last year, up 57% from the year prior.
• Consumers are relying on home delivery for many goods, including cannabis.
• With its Nug Avenue acquisition, SGMD plans to make significant impact on LA cannabis delivery marketplace.

Boasting the largest state economy in the country and the sixth largest economy in the world, California also tops the global marijuana market, with a Forbes article reporting that cannabis sales in the state hit$4.4 billion last year, up 57% from the year prior (https://ibn.fm/Dj8Rl). With much of that growth driven by increased use of delivery services as consumers are increasingly relying on home delivery for many goods, including cannabis, Sugarmade Inc. (OTC: SGMD) is leveraging its position as a 70% stakeholder in NUG Avenue, a cannabis delivery service based in Southern California. Cannabis delivery is key to California’s cannabis growth, according to the Forbes article, which noted that “interesting findings from the report include the massive influx in delivery sales, as well as consumers who used delivery for the first time this year. The peak for first-time delivery users was March and April 2020, coinciding with lockdowns. Many cannabis industry operators saw the most consistent April sales ever. Eaze reports a 59% increase in new customer sign-ups, a 44% increase in first-time deliveries and a 15% increase in order volume.” Those numbers come as no surprise to Sugarmade, an innovator in the dynamic California cannabis scene that has made a significant investment in the cannabis-delivery space. Earlier this year, SGMD announced its Nug acquisition, along with unveiling a new business initiative for the licensed delivery of cannabis products to consumers in the Los Angeles metropolitan area (https://ibn.fm/2iQUN). “We strongly believe the LA delivery market is the prime spot for expansion of our business,” said Sugarmade CEO Jimmy Chan. “California is the world’s sixth-largest economy, and LA County is by far the most significant driver, with over 25% of the state’s population. The Lynwood, California, site is optimal, as it is located along one of the major distribution freeways, allowing drivers to efficiently reach the more than 15 million consumers that live within a 30-mile radius of the new location. We plan to make a big impact on the LA cannabis delivery marketplace.” Sugarmade’s acquisition agreement, which outlines a 70% stake in the Lynwood, California, operations of Nug Avenue, a California corporation, also indicates the company will recognize 70% of the revenues and profits from Nug Avenue’s Lynwood delivery service operations. In addition, the agreement gives SGMD first rights of refusal on all future investments into Nug Avenue and an option on all future business operations, including expansion into additional delivery areas. Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes NUG Avenue, CarryOutsupplies.com and SugarRush(TM). To learn more about Sugarmade, please visit www.sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• Singapore-based fandom fintech firm BAND Royalty has introduced its revolutionary music NFTs that include a royalty revenue-sharing platform
• The NFTs’ art DeFi utility features royalties from select songs by popular artists including Cher, Beyonce, will.i.am and Justin Timberlake
• The NFTs are produced as “albums” of differing degrees of rarity and staking power
• Art NFTs, including those anchored to the music industry, have been growing in popularity in recent years and BAND is the first company to establish its own music-only NFT trading marketplace

By now the cat is well out of the bag that non-fungible tokens (“NFTs”) are trending with a growing role in the music industry, catering to fans’ desires to hold collectibles representing their favorite artists but also to fans’ hopes of turning a little profit on the collectibles trading scene (https://ibn.fm/v9p7B). The rise of music NFTs follows on the heels of low-tech vinyl recordings’ resurgence over the past 15 years, accelerated to overdrive during the past year’s pandemic conditions as an apparent result of fans’ desires for art that transcends the listening experience — especially in the absence of concert events. A report by VICE noted that the vinyl market grew 28.7% in 2020, outperforming CDs in revenues for the first time since the 1980s and stressing the supply chain (https://ibn.fm/LCA0Y). Singapore-based BAND Royalty is disrupting the music industry revenue stream as the first creator of a music-only NFT marketplace tied to the royalties from leading artists. The NFTs will soon be tokenized to allow even more people to get involved. BAND Royalty issued its first series of 3,000 NFTs in May, beginning with a private pre-sale and then open public access to the remaining NFT “albums.” BAND’s NFT marketplace can be found on its website, where three additional series of NFT albums will also appear during the coming year, each with 3,000 new NFTs of varying rarity and staking power to comprise 12,000 BAND NFTs in total once the rollout is completed. The NFTs can be staked in royalty pools established by the company, meaning they are secured to the platform without the option of being traded elsewhere for a specified period of time. The pools include the opportunity for stakeholders to share a percentage of the royalty revenues derived from select pieces of music as they are either performed mechanically or publicly, sold in printed form or synchronized with visual media such as film, advertisements and video games. BAND has purchased these royalty rights for selections by artists including Cher, Beyonce, will.i.am and Justin Timberlake for the current series. The NFTs feature digital works of art that may enhance their value as collectibles that can be traded or sold to other fans. “What we’re doing with non-fungible tokens is so off the charts that no one has seen it before,” BAND co-founder Noble Drakoln said during a live-streamed raffle of one of the NFT “albums” May 27 (https://ibn.fm/l4FZQ). “What we decided to do is to make a full-blown eco-system. The NFTs are the base of system. … We really wanted to make sure that we had from day one a global enterprise that was already crypto accessible. Because as we expand in this ecosystem our goal is just to make the process of collecting music royalties a lot more transparent for the artists and to get them to their fans a lot faster.” For more information on BAND Royalty, visit the company’s website at www.BandRoyalty.com. NOTE TO INVESTORS: The latest news and updates relating to BAND are available in the company’s newsroom at https://ibn.fm/BAND

• Most recently SGMD signed MOU to obtain three non-storefront California cannabis licenses.
• Sugarmade plans to open three new Nug Avenue cannabis delivery hubs in the Los Angeles metro area.
• In May, the company completed the acquisition of Lemon Glow Company Inc., along with all of its assets, interests, property and rights.

In a series of strategic acquisitions, Sugarmade Inc. (OTC: SGMD) has strengthened its position as a growing presence in the California cannabis sector. The company, which is currently a central player in the state’s expanding cannabis delivery space, is focused on developing a full farm-to-door vertically integrated cannabis business. In the company’s most recent move, Sugarmade signed a memorandum of understanding to obtain three non-storefront California cannabis licenses from the Los Angeles Department of Cannabis Regulation, along with corresponding licenses from the California Bureau of Cannabis Control (https://ibn.fm/U63Am). Combined, the licenses provide the foundation for the opening of three new Nug Avenue cannabis delivery hubs in the Los Angeles metro area; Sugarmade currently owns a 70% stake in NUG Avenue, a cannabis delivery service based in southern California that offers hand-selected, top-shelf cannabis products. “Our first Nug Avenue location has been a tremendous success, but we need to expand due to overwhelming demand,” said Sugarmade CEO Jimmy Chan. “Holding these licenses will provide an optimal solution to our current growth limitations. By using these licenses to cover manufacturing, distribution and delivery, we hope to further develop our fully vertical approach to the dynamic California cannabis delivery market. With this agreement, we gain the potential to manufacture and package our own cannabis products, distribute them to multiple Nug Avenue locations, and then deliver them right to the front door of our loyal customer base, driving both top-line and bottom-line growth potential as we expand our footprint in this rapidly growing space.” Just a month earlier, in May, Sugarmade completed the acquisition of Lemon Glow Company Inc., along with all of its assets, interests, property and rights; a key piece of the acquisition included 640 acres of Lake County real estate located outside of the commercial cannabis cultivation exclusion zones (https://ibn.fm/kQ4Sg). According to the company, 32 acres of the property have already been designated for outdoor cannabis cultivation, and the annual potential cultivation yield at the property is estimated to be approximately 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total. “This step brings us closer to closing the loop on what we believe to be one of the most promising vertically integrated cannabis models in the thriving California market,” said Chan. “We are setting the stage to improve margins while expanding end-market access, and to grow, refine, produce, distribute, sell, and home-deliver top cannabis products in the largest and fastest growing cannabis market on the planet. This acquisition positions us to achieve that objective with a significant capacity to scale as demand for our products and services grows over time.” Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes NUG Avenue, CarryOutsupplies.com and SugarRush(TM). To learn more about Sugarmade, please visit www.sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• The first container of mixed RE carbonate has been shipped from the United States to Europe.
• The announcement marks important achievement, not only for UUUU and NEO, but also for U.S. government efforts to restore critical rare earth supply chains.
• Energy Fuels is the only North American company that currently produces a monazite-derived, enhanced rare earth material.

A milestone has been reached in the quest to create a new rare earth supply chain based in the United States. Energy Fuels (NYSE American: UUUU) (TSX: EFR) and Neo Performance Materials (TSX: NEO) have announced that the first container of mixed rare earth (“RE”) carbonate has been shipped from UUUU’s White Mesa Mill in Utah to NEO’s rare earth separation facility in Estonia, creating a new United States-to-Europe rare earth supply chain. “Today, Energy Fuels and Neo took significant steps toward restoring critical U.S. and European rare earth supply chains,” said Energy Fuels president and CEO Mark S. Chalmers. “Energy Fuels has methodically ramped up our mixed rare earth carbonate production since we first started feeding Georgia monazite ore into our Utah mill in March. “Successfully producing this rare earth product, and physically delivering the first containers of rare earth carbonate to Neo, is an important achievement, not only for Energy Fuels and Neo, but also for U.S. government efforts to restore critical rare earth supply chains,” Chalmers continued. “This is also very good news for end users of rare earth products in the U.S., Europe, Japan and elsewhere who seek alternative sources of rare earths produced in the U.S. and Europe to the highest global standards of environmental protection and sustainability.” The initial container, approximately 20 tonnes of product, is the first of 15 containers expected to be shipped to Estonia in the coming weeks. The new supply chain begins in the state of Georgia, where Chemours (NYSE: CC) mines natural monazite sand ore, or monazite, that contains both the rare earth elements and naturally occurring uranium. The rare earth elements are then processed into RE carbonate by UUUU’s White Mesa Mill before it is shipped off to Estonia and separated into rare earth oxides and other value-added rare earth compounds. This commercial-scale process has established Energy Fuels as the only company in North America that currently produces a monazite-derived, enhanced rare earth material, and the shipment of the product represents the beginning of a new, environmentally responsible rare earth supply chain. This new supply chain could benefit manufacturers of electric vehicles (“EVs”), renewable energy systems and other users of rare earths in North America, Europe and Japan, as well as other nations. “The launch of this new supply chain is a real gamechanger for Neo and our growing customer base in Europe,” said Neo’s CEO Constantine Karayannopoulos. “This innovative U.S.-to-Europe supply chain will supplement Neo’s existing rare earth supply from our long-time Russian supplier. It will enable Neo to expand value-added rare earth production in Estonia to meet growing demand in Europe for these materials. It begins to unlock the extraordinary economic and environmental potential presented by utilizing low-cost rare earth feedstock from monazite ore that is a byproduct of existing mining. And it helps Neo ramp up rare earth production in Estonia just as Europe accelerates vehicle electrification and other initiatives aimed at mitigating climate impacts.” Energy Fuels is the leading uranium mining company in the United States; the company also produces vanadium from certain of its projects, and it was the nation’s largest producer of this critical mineral in 2019. Vanadium is used in steel, master alloys and emerging utility-scale batteries, with prices up more than 70% this year. Headquartered in Denver, Colorado, UUUU holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• HempFusion Wellness is raising its profile as a CBD-focused health and wellness innovator as it continues to acquire other promising industry players.
• The passage of the U.S. Farm Bill in 2018 drove a fiercely competitive market for hemp-based CBD but a significant decline in the market during the past year’s pandemic has driven a consolidation of brands.
• HempFusion recently completed full acquisition of Sagely Enterprises Inc. (“Sagely Naturals”), which will boost HempFusion’s retail channel by 14,000 outlets.
• CBD remains a go-to option for many Americans seeking relief from post-workout soreness and relaxation. HempFusion’s OTC topicals are designed to meet consumer needs for pain, acne and eczema, while their CBD support capsules offer overall wellness and/or targeted support for sleep, stress or energy.

The trend toward merger and acquisition activity throughout the market for cannabidiol (“CBD”) products reflects a maturation of the fragmented sector and is generating optimism that the brands emerging from this transitional phase will be well equipped to grow during the coming years. “Thirty-five-hundred brands cannot be supported — period — in this industry,” HempFusion Wellness, Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) co-founder and CEO Jason Mitchell told Natural Products Insider in a recent interview acknowledging the number of brands has dropped to 2,000 (https://ibn.fm/BVdqa). “There just isn’t enough consumer interest. It just doesn’t make sense at all.” Mitchell has been bullish about consolidation since just before the global sweep of the COVID-19 virus began battering CBD store fronts and larger national markets in general. HempFusion acquired Probulin Probiotics LLC, in 2019 and has since gone on to announce the proposed 100% acquisition of the holdings company that owns the Apothecanna CBD line (https://ibn.fm/mp9wQ) and, most recently, the completion of its acquisition of Sagely Enterprises Inc. (“Sagely Naturals”), a producer of premium CBD products with mass distribution in more than 14,000 retail outlets nationwide (https://ibn.fm/oI21a). Brightfield Group market analysts Managing Director Bethany Gomez told Natural Products Insider that Hemp-based CBD sales grew 560% in 2019 on the heels of the December 2018 passage of Farm Bill legislation legalizing once-banned hemp production and sales across the United States, but in 2020 the sector’s growth dropped to just 11%. HempFusion’s emphasis on regulatory compliance for hemp-derived products worldwide and its efforts to identify lucrative subsidiary markets are positioning the company to take advantage of ongoing growth in the $4.6 billion channel, which Brightfield expects to bump up to 15% this year for an outcome of $5.3 billion by year’s end. HempFusion ended 2020 with more than $4.19 million in net revenue but expects that number to more than triple in 2021, according to the Sagely announcement. And as advocates continue to push federal marijuana legalization under a newly strengthened Democratic administration (https://ibn.fm/1B6sb), hemp growers are hopeful that any strengthening of marijuana’s profile at the state or federal level will boost de-stigmatization of CBD products in areas where consumers have continued to remain wary thus far because of non-intoxicating hemp’s close familial relationship to the intoxicating hemp that produces marijuana (https://ibn.fm/A6mdT) During the past decade, hemp-based CBD has gained a powerful following because of its reputed usefulness in easing pain and anxiety, particularly in connection with medical conditions including Parkinson’s disease, dementia, diabetes, and multiple sclerosis, as well as epilepsy in children. HempFusion’s products include over-the-counter (“OTC”) therapeutics in the form of topicals, as well as CBD capsules for targeted support, CBD oils and skin-soothing creams, all made using their uniquely pure, organically produced whole food hemp extract. For more information, visit the company’s website at www.hempfusion.com/corporate-information. NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://ibn.fm/CBDHF

• InnerScope is a direct-to-consumer manufacturer, distributor and retailer of FDA-registered Bluetooth app-controlled self-adjusting hearing aids and personal sound amplifiers products, doctor-formulated dietary hearing and tinnitus supplements, and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems
• The company provides ear care and cleaning solutions for a total packaged service
• Free hearing testing can be completed on the company’s website and on the app to determine if hearing loss has occurred and if a hearing aid or sound amplification device is the best fit
• The company’s self-service fully automated hearing screening kiosks target an additional 41 million Americans who may not have access to an audiologist – also doubling as a point-of-sale system for the InnerScope hearing aid products
• InnerScope’s self-service fully automated hearing screening kiosks will be deployed in big box retailers, grocery stores, pharmacies and other public spaces; InnerScope has received interest from dozens of businesses and has already numerous signed contracts to launch hearing screening kiosks in the coming months in over nine states
• InnerScope has been in the retail hearing device business for over 70 years; each member of its management team started in the industry at an early age

InnerScope Hearing Technologies (OTC: INND) is a Nevada corporation incorporated on June 15, 2012, with its principal place of business in Roseville, California. The company was initially started in 2006 – operating as InnerScope Advertising Agency Inc. – to provide advertising and marketing services to retail establishments in the hearing device industry. On August 25, 2017, the company changed its name to InnerScope Hearing Technologies Inc. to better reflect its current direction as a hearing health technology company that manufactures, develops, distributes and sells numerous innovative hearing health-related products, hearing treatments and hearing solutions, direct-to-consumer (“DTC”) through a scalable business model. The company is a manufacturer and a distributor/retailer of DTC, FDA (U.S. Food and Drug Administration) registered, Bluetooth app-controlled hearing aids and personal sound amplifier products (“PSAPs”), hearing-related treatment therapies, doctor-formulated dietary hearing supplements, proprietary CDB oil for treating tinnitus and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems. The company’s mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues. The management team of InnerScope is applying decades of industry experience and believes it is well-positioned, with its innovative in-store point-of-sale Free Self-Check Hearing Screening Kiosks (“Hearing Kiosks”), to directly benefit when the Over the Counter (“OTC”) Hearing Aid Act (the “OTC Hearing Aid Law”) is enacted (expected in late 2021 based on the President’s Executive Order issued on July 9, 2021) The OTC Hearing Aid Law allows OTC hearing aids for perceived mild-to-moderate hearing losses to be sold in retail stores without having to see a professional. InnerScope’s Hearing Kiosk is designed to help the tens of millions of Americans with undetected/untreated mild-to-moderate hearing loss treat themselves with the company’s easy, convenient and affordable OTC hearing aids, in-store and/or online. Industry Game-Changer – New Emerging Market with 48 Million Potential Customers The following is sourced from The White House Fact Sheet detailing an Executive Order from President Biden aimed at saving Americans with hearing loss thousands of dollars by allowing hearing aids to be sold over the counter at drug stores: “Hearing Aids: Hearing aids are so expensive that only 14% of the approximately 48 million Americans with hearing loss use them. On average, they cost more than $5,000 per pair, and those costs are often not covered by health insurance. A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary. Rather, this requirement serves only as red tape and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market.” On July 9, 2021, President Biden noted the following in reference to his Executive Order relating to hearing aids: “Right now, if you need a hearing aid, you can’t just walk into a pharmacy and pick one up over the counter. You have to get it from a doctor or a specialist. Not only does that make getting hearing aids inconvenient, it makes them considerably more expensive, and it makes it harder for new companies to compete, innovate and sell hearing aids at lower prices.” “As a result, a pair of hearing aids can cost thousands of dollars. That’s a big reason why just one in seven Americans with hearing loss actually use a hearing aid.” InnerScope Game-Changers For InnerScope, this Executive Order could present a significant opportunity. The company is uniquely positioned with a number of strategic advantages and offerings in the space, including:

• First to Market: Free self-check hearing screening kiosks deployed in national pharmacy chains, big-box retailers & national and local groceries chains
• Online Hearing Screening Tests: For national retailers to use their websites to attract more customers in conjunction with the company’s in-store hearing kiosks
• The HearIQ App for iOS and Android users: Offers a free self-check hearing test and provides a user control function for InnerScope’s Bluetooth app-controlled self-adjusting rechargeable hearing devices
• Customer Monthly Subscription Model: Offering the lowest, most affordable monthly payment options (as low as $42 per month for pair of rechargeable, app-controlled hearing aids) for consumers to purchase hearing aids and receive free upgrades every two years

The In-Store Hearing Screening Kiosks and Online Free Hearing Screening Tests Innerscope’s hearing screening kiosk and online hearing screening tests offer free self-check hearing evaluation using the world’s first “Hearing Triage” artificial intelligent pattern recognition software, which has a unique ability to classify both level (degree of loss) and pattern (type of loss). In addition, the software can detect the probable location of the hearing problem and its degree of severity. The tests are developed as a hearing wellness tool to help track hearing ability and (if tests results indicate a hearing loss) make recommendations for in-store point of sale or online purchase of one of InnerScope’s hearing devices, as well as providing recommendations to see one of the professionals in InnerScope’s local contracted network of hearing health care experts for further follow-up testing if necessary. The software also generates an audiometric report which is instantly emailed to the customer. The HearIQ App InnerScope is the creator of the HearIQ App, which offers free self-check hearing tests and provides a user control function for InnerScope’s line of Bluetooth app-controlled self-adjusting rechargeable hearing devices. InnerScope developed the free hearing test part of the HearIQ App to help with the early detection of hearing loss for the 1.5 billion people worldwide who have untreated hearing loss or some form of hearing issues that may be undetected and do not have access to a computer for InnerScope’s online hearing screening test. Hearing Aid Products Through its dedicated online store, MyHearIQ.com, InnerScope offers affordable, direct-to-consumer, Bluetooth app-controlled, self-adjusting hearing technology to empower consumers to take control of their hearing care. InnerScope’s hearing technology allows the customer in less than 10 minutes using any smartphone to personalize each hearing device to their hearing needs using an onboard in-ear custom-fit self-testing feature through the HearIQ App. InnerScope is shifting hearing health care from traditional brick-and-mortar hearing care clinics to customers’ homes by providing a unique solution to give customers top quality, affordable access to hearing aids without the need to see a hearing professional or go to a hearing care clinic. As a result, InnerScope can deliver the same level and quality of hearing technology and expert support for the customer from their homes at a fraction of the cost of traditional channels. All InnerScope hearing aid devices are medical-grade and available with professional remote programming and support services from one of the company’s licensed hearing professionals through the HearIQ App. Hearing & Tinnitus Dietary Supplements InnerScope has developed a proprietary line of doctor-designed hearing & tinnitus dietary supplements to help people with hearing problems protect themselves from future hearing issues. There are currently three types of formulas to choose from, including Ear-Ring Relief for the 60 million Americans who suffer from tinnitus, HearingVite + Memory Boost for people with hearing loss and cognitive issues, and HearingVite + Multivitamin for maintaining proper hearing health and levels of nutrients. Complete Line of Hearing Health Care Products InnerScope offers a brand label of assorted ear care and hearing aid maintenance products. In support of overall ear health and ensuring maximum performance from its hearing aids and comfort for its customers, InnerScope provides a whole line of care items, including cleaning kits, wipes, spray and drying tablets, ear cleaner for wax removal, a natural lubricant agent for new hearing aids and hydrating lubricating ear gel. Verified Wholesale and Direct-to-Consumer Sales InnerScope is a verified wholesaler with Walmart for premium affordable direct-to-consumer hearing aids, personal sound amplification and hearing health accessories. InnerScope also created an easy shopping experience for its hearing and tinnitus vitamins through Walmart and Amazon Prime. With new partnerships in the works, the company aims to add other online and brick-and-mortar establishments to its vitamin distribution network in the future. Hearing Aid Market Outlook The global hearing aid market is expected to reach $11.02 billion by 2028, growing at a CAGR of 7.4% during the forecast period. This marks a significant increase from the $6.47 billion value reported in 2020, an increase largely driven by innovations being made in hearing aid technology (https://ibn.fm/bRWUb). As a leading wholesale provider and direct-to-consumer business, InnerScope is positioned to disrupt the global hearing aid market. Its partnerships with some of the United States’ largest retail distributors and wholesalers are only strengthening the company’s position within the industry. Management Team Matthew Moore is the President and CEO of InnerScope Hearing Technologies Inc. He grew up in the hearing health industry, working alongside his grandfather through internships and mentorships. At the age of 10 years old, he became Chief Marketing Officer and Chief Operating Officer of his parent’s private hearing aid practice, the largest in Northern California and the second largest in the state. Matthew has shown his leadership ability by creating distribution partnerships with big industry names and independent retailers/pharmacies. Kim Moore is the Chief Financial Officer of InnerScope Hearing Technologies Inc. She has worked in the hearing aid industry for over 45 years, helping her father maintain his hearing aid practice in Central Valley, California. She began working on marketing with her father at the age of eight, learning that no customer walks through the door without proper advertising and marketing. As a licensed hearing instrument specialist, Kim has given hearing tests to more than 30,000 people. Mark Moore is the Chairman and Co-Founder of InnerScope Hearing Technologies Inc. He has over 35 years of experience in hearing aid dispensing, practice management, private label brand management and hearing aid marketing. He has personally fit hearing aids to over 10,000 hearing-impaired people. In addition, he has been responsible for developing and testing proven new industry marketing and advertising methods and best practice strategies, which has made him one of the most sought-after experts in the hearing aid industry. Mark was previously a columnist for Advanced for Audiologists, a global industry publication, and served on the American Academy of Audiology (“AAA”) advisory board for AudiologyNow conventions. He has also developed patented and patent-pending nutritional supplements for hearing-related issues, aural rehabilitation programs and low-level laser therapy for tinnitus and sensorineural hearing loss. For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND